Updated On: 08 December, 2020 05:36 PM IST | Mumbai | IANS
BE will be responsible for the evaluation and further development, including the commercialisation of the vaccine candidates

Picture used for representational purpose only
Biological E. Ltd, a Hyderabad-based vaccine and pharmaceutical company, and the Ohio State Innovation Foundation on Tuesday announced an exclusive license agreement for a Covid-19 vaccine technology.
The Ohio State Innovation Foundation has licensed novel live attenuated measles virus vectored vaccine candidates against SARS-CoV-2, which were developed by the Ohio State University College of Veterinary Medicine, exclusively to Biological E.